Evidence map›Paper›PMID 37074178›Full record

ArticlemBio2023

Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection.

Terry Zhou, Nora J Gilliam, Sizhen Li, Simone Spandau, Raven M Osborn, Sarah Connor, Christopher S Anderson, Thomas J Mariani, Juilee Thakar, Stephen Dewhurst and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Terry Zhou *Department of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
Nora J Gilliam *Department of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
Sizhen Li *School of Electrical Engineering & Computer Science, Oregon State University, Corvallis, Oregon, USA.
Simone Spandau *Department of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
Raven M OsbornDepartment of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
Sarah ConnorDepartment of Pediatrics and Center for Children's Health Research, University of Rochester, Rochester, New York, USA.
Christopher S AndersonDepartment of Pediatrics and Center for Children's Health Research, University of Rochester, Rochester, New York, USA.ORCID 0000-0002-8560-3438
Thomas J MarianiDepartment of Pediatrics and Center for Children's Health Research, University of Rochester, Rochester, New York, USA.
Juilee ThakarDepartment of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
Stephen DewhurstDepartment of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
David H MathewsDepartment of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester Medical Center, Rochester, New York, USA.
Liang HuangSchool of Electrical Engineering & Computer Science, Oregon State University, Corvallis, Oregon, USA.
Yan SunDepartment of Immunology and Microbiology, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-5320-5793
University of Rochester Medical Center · USThe Harley School · USOregon State University · US

Funding

University of Rochester Mentoring Environment: Nurturing Training Opportunities in Research (UR-MENTOR)T32GM007356 · NIGMS · UNIVERSITY OF ROCHESTER · PI O'BANION, M. KERRY · 1985 to 2023
$15.1M
BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase IIIU01HL148861 · NHLBI · UNIVERSITY OF ROCHESTER · PI GLORIA S PRYHUBER · 2019 to 2026
$9.7M
Biorepository for Investigation of Neonatal Diseases of Lung-Normal (BRINDL-NL)U01HL122700 · NHLBI · UNIVERSITY OF ROCHESTER · PI PRYHUBER, GLORIA S · 2014 to 2018
$6.1M
NRSA Training CoreTL1TR002000 · NCATS · UNIVERSITY OF ROCHESTER · PI THAKAR, JUILEE, VAN WIJNGAARDEN, EDWIN · 2016 to 2024
$4.1M
RNA Structure Modeling Using Physics and Sequence ComparisonR35GM145283 · NIGMS · UNIVERSITY OF ROCHESTER · PI DAVID H. MATHEWS · 2022 to 2026
$2.7M
NCATS NIH HHS TL1 TR002000NHLBI NIH HHS U01 HL122700NHLBI NIH HHS U01 HL148861NIGMS NIH HHS R35 GM145283NIGMS NIH HHS T32 GM007356
6 · The paper itself

Abstract

Defective viral genomes (DVGs) have been identified in many RNA viruses as a major factor influencing antiviral immune response and viral pathogenesis. However, the generation and function of DVGs in SARS-CoV-2 infection are less known. In this study, we elucidated DVG generation in SARS-CoV-2 and its relationship with host antiviral immune response. We observed DVGs ubiquitously from transcriptome sequencing (RNA-seq) data sets of

Indexed as

COVID-19RNA VirusesAntiviral AgentsCohort StudiesGenome, ViralHumansRNA, ViralSARS-CoV-2Antiviral AgentsRNA, Viraldefective viral genomeshuman epithelial cellsrecombinationRNA secondary structureSARS-CoV-2secondary structuretype I/III IFN responses

Identifiers

PMID37074178
PMCPMC10294654
OpenAlexW4366351736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.